{
  "DOI": "10.1007/s10689-014-9754-z",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-014-9754-z",
  "alternative-id": [
    "9754"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Etzold",
      "given": "Anna",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Schröder",
      "given": "Julia C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bartsch",
      "given": "Oliver",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zechner",
      "given": "Ulrich",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Galetzka",
      "given": "Danuta",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2014,
        9,
        16
      ]
    ],
    "date-time": "2014-09-16T08:40:27Z",
    "timestamp": 1410856827000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        8,
        15
      ]
    ],
    "date-time": "2019-08-15T01:22:32Z",
    "timestamp": 1565832152000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        5,
        10
      ]
    ],
    "date-time": "2023-05-10T23:07:17Z",
    "timestamp": 1683760037341
  },
  "is-referenced-by-count": 6,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2014,
        9,
        17
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2015,
          3
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2014,
            9,
            17
          ]
        ],
        "date-time": "2014-09-17T00:00:00Z",
        "timestamp": 1410912000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9754-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-014-9754-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9754-z",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "161-165",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2014,
        9,
        17
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2014,
        9,
        17
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2015,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "KE Nichols",
      "first-page": "83",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9754_CR1",
      "unstructured": "Nichols KE, Malkin D, Garber JE et al (2001) Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 10:83–87",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1186/1471-2407-12-217",
      "author": "K Kast",
      "doi-asserted-by": "crossref",
      "first-page": "217",
      "journal-title": "BMC Cancer",
      "key": "9754_CR2",
      "unstructured": "Kast K, Krause M, Schuler M et al (2012) Late onset Li–Fraumeni syndrome with bilateral breast cancer and other malignancies: case report and review of the literature. BMC Cancer 12:217. doi: 10.1186/1471-2407-12-217",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1097/01.mph.0000176732.68090.c8",
      "author": "ME Cavalier",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "journal-title": "J Pediatr Hematol Oncol",
      "key": "9754_CR3",
      "unstructured": "Cavalier ME, Davis MM, Croop JM (2005) Germline p53 mutation presenting as synchronous tumors. J Pediatr Hematol Oncol 27:441–443",
      "volume": "27",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/90.8.606",
      "author": "M Hisada",
      "doi-asserted-by": "crossref",
      "first-page": "606",
      "journal-title": "J Natl Cancer Inst",
      "key": "9754_CR4",
      "unstructured": "Hisada M, Garber JE, Fung CY et al (1998) Multiple primary cancers in families with Li–Fraumeni syndrome. J Natl Cancer Inst 90:606–611",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1038/sj.onc.1204621",
      "author": "JM Birch",
      "doi-asserted-by": "crossref",
      "first-page": "4621",
      "journal-title": "Oncogene",
      "key": "9754_CR5",
      "unstructured": "Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628. doi: 10.1038/sj.onc.1204621",
      "volume": "20",
      "year": "2001"
    },
    {
      "DOI": "10.1001/jama.1982.03320440040031",
      "author": "FP Li",
      "doi-asserted-by": "crossref",
      "first-page": "2692",
      "journal-title": "JAMA",
      "key": "9754_CR6",
      "unstructured": "Li FP, Fraumeni JF (1982) Prospective study of a family cancer syndrome. JAMA 247:2692–2694",
      "volume": "247",
      "year": "1982"
    },
    {
      "DOI": "10.1136/jmg.38.1.43",
      "author": "A Chompret",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "journal-title": "J Med Genet",
      "key": "9754_CR7",
      "unstructured": "Chompret A, Abel A, Stoppa-Lyonnet D et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43–47",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7967",
      "author": "J Tinat",
      "doi-asserted-by": "crossref",
      "first-page": "e108",
      "journal-title": "J Clin Oncol",
      "key": "9754_CR8",
      "unstructured": "Tinat J, Bougeard G, Baert-Desurmont S et al (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27:e108–e109. doi: 10.1200/JCO.2009.22.7967 ; author reply e110",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1002/humu.10185",
      "author": "JM Varley",
      "doi-asserted-by": "crossref",
      "first-page": "313",
      "journal-title": "Hum Mutat",
      "key": "9754_CR9",
      "unstructured": "Varley JM (2003) Germline TP53 mutations and Li–Fraumeni syndrome. Hum Mutat 21:313–320. doi: 10.1002/humu.10185",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1038/35106009",
      "author": "T Soussi",
      "doi-asserted-by": "crossref",
      "first-page": "233",
      "journal-title": "Nat Rev Cancer",
      "key": "9754_CR10",
      "unstructured": "Soussi T, Béroud C (2001) Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1:233–240. doi: 10.1038/35106009",
      "volume": "1",
      "year": "2001"
    },
    {
      "author": "M Olivier",
      "first-page": "6643",
      "journal-title": "Cancer Res",
      "key": "9754_CR11",
      "unstructured": "Olivier M, Goldgar DE, Sodha N et al (2003) Li–Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643–6650",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1073/pnas.1431692100",
      "author": "S Kato",
      "doi-asserted-by": "crossref",
      "first-page": "8424",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "9754_CR12",
      "unstructured": "Kato S, Han S-Y, Liu W et al (2003) Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100:8424–8429. doi: 10.1073/pnas.1431692100",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1002/(SICI)1097-0215(19981029)78:3\u003c372::AID-IJC19\u003e3.0.CO;2-8",
      "author": "C Rollenhagen",
      "doi-asserted-by": "crossref",
      "first-page": "372",
      "journal-title": "Int J Cancer",
      "key": "9754_CR13",
      "unstructured": "Rollenhagen C, Chène P (1998) Characterization of p53 mutants identified in human tumors with a missense mutation in the tetramerization domain. Int J Cancer 78:372–376. doi: 10.1002/(SICI)1097-0215(19981029)78:3\u003c372:AID-IJC19\u003e3.0.CO;2-8",
      "volume": "78",
      "year": "1998"
    },
    {
      "DOI": "10.1074/jbc.M110.174698",
      "author": "R Kamada",
      "doi-asserted-by": "crossref",
      "first-page": "252",
      "journal-title": "J Biol Chem",
      "key": "9754_CR14",
      "unstructured": "Kamada R, Nomura T, Anderson CW, Sakaguchi K (2011) Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation. J Biol Chem 286:252–258. doi: 10.1074/jbc.M110.174698",
      "volume": "286",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nsb730",
      "author": "EL DiGiammarino",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "journal-title": "Nat Struct Biol",
      "key": "9754_CR15",
      "unstructured": "DiGiammarino EL, Lee AS, Cadwell C et al (2002) A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 9:12–16. doi: 10.1038/nsb730",
      "volume": "9",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10689-009-9284-2",
      "author": "L Fiszer-Maliszewska",
      "doi-asserted-by": "crossref",
      "first-page": "541",
      "journal-title": "Fam Cancer",
      "key": "9754_CR16",
      "unstructured": "Fiszer-Maliszewska L, Kazanowska B, Padzik J (2009) p53 Tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li–Fraumeni syndrome and a child with adrenocortical carcinoma. Fam Cancer 8:541–546. doi: 10.1007/s10689-009-9284-2",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cncr.25826",
      "author": "AL Seidinger",
      "doi-asserted-by": "crossref",
      "first-page": "2228",
      "journal-title": "Cancer",
      "key": "9754_CR17",
      "unstructured": "Seidinger AL, Mastellaro MJ, Paschoal Fortes F et al (2011) Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil. Cancer 117:2228–2235. doi: 10.1002/cncr.25826",
      "volume": "117",
      "year": "2011"
    },
    {
      "author": "JM Varley",
      "first-page": "2437",
      "journal-title": "Oncogene",
      "key": "9754_CR18",
      "unstructured": "Varley JM, McGown G, Thorncroft M et al (1996) A previously undescribed mutation within the tetramerization domain of TP53 in a family with Li–Fraumeni syndrome. Oncogene 12:2437–2442",
      "volume": "12",
      "year": "1996"
    },
    {
      "DOI": "10.1002/humu.20495",
      "author": "A Petitjean",
      "doi-asserted-by": "crossref",
      "first-page": "622",
      "journal-title": "Hum Mutat",
      "key": "9754_CR19",
      "unstructured": "Petitjean A, Mathe E, Kato S et al (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28:622–629. doi: 10.1002/humu.20495",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.onc.1204373",
      "author": "P Chène",
      "doi-asserted-by": "crossref",
      "first-page": "2611",
      "journal-title": "Oncogene",
      "key": "9754_CR20",
      "unstructured": "Chène P (2001) The role of tetramerization in p53 function. Oncogene 20:2611–2617. doi: 10.1038/sj.onc.1204373",
      "volume": "20",
      "year": "2001"
    },
    {
      "DOI": "10.1002/j.1460-2075.1993.tb06199.x",
      "author": "TD Halazonetis",
      "doi-asserted-by": "crossref",
      "first-page": "5057",
      "journal-title": "EMBO J",
      "key": "9754_CR21",
      "unstructured": "Halazonetis TD, Kandil AN (1993) Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J 12:5057–5064",
      "volume": "12",
      "year": "1993"
    },
    {
      "DOI": "10.1074/jbc.M805696200",
      "author": "Y Itahana",
      "doi-asserted-by": "crossref",
      "first-page": "5158",
      "journal-title": "J Biol Chem",
      "key": "9754_CR22",
      "unstructured": "Itahana Y, Ke H, Zhang Y (2009) p53 Oligomerization is essential for its C-terminal lysine acetylation. J Biol Chem 284:5158–5164. doi: 10.1074/jbc.M805696200",
      "volume": "284",
      "year": "2009"
    },
    {
      "DOI": "10.1101/gad.12.18.2831",
      "author": "K Sakaguchi",
      "doi-asserted-by": "crossref",
      "first-page": "2831",
      "journal-title": "Genes Dev",
      "key": "9754_CR23",
      "unstructured": "Sakaguchi K, Herrera JE, Saito S et al (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12:2831–2841",
      "volume": "12",
      "year": "1998"
    },
    {
      "DOI": "10.1074/jbc.274.23.16531",
      "author": "CG Maki",
      "doi-asserted-by": "crossref",
      "first-page": "16531",
      "journal-title": "J Biol Chem",
      "key": "9754_CR24",
      "unstructured": "Maki CG (1999) Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2. J Biol Chem 274:16531–16535",
      "volume": "274",
      "year": "1999"
    },
    {
      "DOI": "10.4161/cbt.7.9.6473",
      "author": "LJ Warnock",
      "doi-asserted-by": "crossref",
      "first-page": "1481",
      "journal-title": "Cancer Biol Ther",
      "key": "9754_CR25",
      "unstructured": "Warnock LJ, Knox A, Mee TR et al (2008) Influence of tetramerisation on site-specific post-translational modifications of p53: comparison of human and murine p53 tumor suppressor protein. Cancer Biol Ther 7:1481–1489",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1177/1947601911413466",
      "author": "D Malkin",
      "doi-asserted-by": "crossref",
      "first-page": "475",
      "journal-title": "Genes Cancer",
      "key": "9754_CR26",
      "unstructured": "Malkin D (2011) Li–Fraumeni syndrome. Genes Cancer 2:475–484. doi: 10.1177/1947601911413466",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S1470-2045(11)70119-X",
      "author": "A Villani",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "journal-title": "Lancet Oncol",
      "key": "9754_CR27",
      "unstructured": "Villani A, Tabori U, Schiffman J et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li–Fraumeni syndrome: a prospective observational study. Lancet Oncol 12:559–567. doi: 10.1016/S1470-2045(11)70119-X",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10897-012-9556-0",
      "author": "B Fresneau",
      "doi-asserted-by": "crossref",
      "first-page": "315",
      "journal-title": "J Genet Couns",
      "key": "9754_CR28",
      "unstructured": "Fresneau B, Brugières L, Caron O, Moutel G (2013) Ethical issues in presymptomatic genetic testing for minors: a dilemma in Li–Fraumeni syndrome. J Genet Couns 22:315–322. doi: 10.1007/s10897-012-9556-0",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10689-009-9245-9",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "journal-title": "Fam Cancer",
      "key": "9754_CR29",
      "unstructured": "Evans DG, Lunt P, Clancy T, Eeles R (2010) Childhood predictive genetic testing for Li–Fraumeni syndrome. Fam Cancer 9:65–69. doi: 10.1007/s10689-009-9245-9",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.cancergen.2012.06.008",
      "author": "PL Mai",
      "doi-asserted-by": "crossref",
      "first-page": "479",
      "journal-title": "Cancer Genet",
      "key": "9754_CR30",
      "unstructured": "Mai PL, Malkin D, Garber JE et al (2012) Li–Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet 205:479–487. doi: 10.1016/j.cancergen.2012.06.008",
      "volume": "205",
      "year": "2012"
    },
    {
      "DOI": "10.1001/jama.299.11.1315",
      "author": "S Masciari",
      "doi-asserted-by": "crossref",
      "first-page": "1315",
      "journal-title": "JAMA",
      "key": "9754_CR31",
      "unstructured": "Masciari S, Van den Abbeele AD, Diller LR et al (2008) F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li–Fraumeni syndrome. JAMA 299:1315–1319. doi: 10.1001/jama.299.11.1315",
      "volume": "299",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2009.27.2112",
      "author": "CRM Lammens",
      "doi-asserted-by": "crossref",
      "first-page": "3008",
      "journal-title": "J Clin Oncol",
      "key": "9754_CR32",
      "unstructured": "Lammens CRM, Aaronson NK, Wagner A et al (2010) Genetic testing in Li–Fraumeni syndrome: uptake and psychosocial consequences. J Clin Oncol 28:3008–3014. doi: 10.1200/JCO.2009.27.2112",
      "volume": "28",
      "year": "2010"
    }
  ],
  "reference-count": 32,
  "references-count": 32,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-014-9754-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li–Fraumeni syndrome"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}